Rafferty Asset Management’s ResMed RMD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$4M Buy
15,491
+1,895
+14% +$489K 0.01% 440
2025
Q1
$3.04M Sell
13,596
-3,054
-18% -$684K 0.01% 475
2024
Q4
$3.81M Buy
16,650
+693
+4% +$158K 0.01% 466
2024
Q3
$3.9M Sell
15,957
-11
-0.1% -$2.69K 0.01% 473
2024
Q2
$3.06M Buy
15,968
+792
+5% +$152K 0.01% 521
2024
Q1
$3.01M Buy
15,176
+200
+1% +$39.6K 0.01% 587
2023
Q4
$2.58M Sell
14,976
-354
-2% -$60.9K 0.01% 610
2023
Q3
$2.27M Buy
15,330
+1,147
+8% +$170K 0.01% 572
2023
Q2
$3.1M Buy
14,183
+1,020
+8% +$223K 0.02% 518
2023
Q1
$2.88M Buy
13,163
+566
+4% +$124K 0.02% 518
2022
Q4
$2.62M Buy
12,597
+4,745
+60% +$988K 0.02% 510
2022
Q3
$1.71M Buy
7,852
+4,303
+121% +$939K 0.02% 544
2022
Q2
$744K Sell
3,549
-921
-21% -$193K 0.01% 728
2022
Q1
$1.08M Sell
4,470
-427
-9% -$104K 0.01% 763
2021
Q4
$1.28M Buy
4,897
+257
+6% +$67K 0.01% 787
2021
Q3
$1.22M Buy
4,640
+1,411
+44% +$372K 0.01% 761
2021
Q2
$796K Buy
3,229
+72
+2% +$17.7K 0.01% 979
2021
Q1
$613K Buy
3,157
+139
+5% +$27K ﹤0.01% 934
2020
Q4
$642K Sell
3,018
-22
-0.7% -$4.68K 0.01% 627
2020
Q3
$521K Sell
3,040
-598
-16% -$102K 0.01% 687
2020
Q2
$698K Buy
3,638
+2,153
+145% +$413K 0.01% 632
2020
Q1
$219K Sell
1,485
-2,397
-62% -$353K 0.01% 507
2019
Q4
$602K Buy
+3,882
New +$602K 0.01% 663